• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Horizon Pharma Inc

+ Add to Watchlist

HZNP:US

13.3700 USD 0.1900 1.44%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Horizon Pharma Inc (HZNP)

Open: 13.2000 Day's Range: 12.8800 - 13.9800 Volume: 2,127,450
Previous Close: 13.1800 52wk Range: 2.1100 - 18.3000 1-Yr Rtn: +447.95%

Stock Chart for HZNP

No chart data available.
  • HZNP:US 13.3700
  • 1D
  • 1M
  • 1Y
13.1800
Interactive HZNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HZNP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 24.8513
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3300
Est. EPS (USD) (12/2014) 0.5380
Est. PEG Ratio 1.2426
Market Cap (M USD) 905.60
Shares Outstanding (M) 67.73
30 Day Average Volume 3,724,757
Price/Book (mrq) -
Price/Sale (ttm) 11.0928
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HZNP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HZNP

Horizon Pharma, Inc., is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation.

Timothy P WalbertChairman/President/CEORobert J De VaereExec VP/CFO/Secretary
Todd N SmithExec VP/Chief Commercial OfficerRobert F Carey "Bob"Exec VP/Chief Business Officer
More Company Profile & Key Executives for HZNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil